Repros (RPRX) Enters $11.1M Direct Placement

Repros Therapeutics Inc. (Nasdaq: RPRX) today announced that it has entered into definitive agreements with certain institutional investors, including certain existing shareholders, to sell an aggregate of 2,463,538 shares of common stock, par value $0.001 per share ("Common Stock") in a registered direct offering for gross proceeds of approximately $11.1 million, before deducting placement agent's fees and estimated offering expenses. The investors have agreed to purchase the shares of Common Stock for a price of $4.50 per share.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Futuremain to merge with ChampionsGate in $80M Nasdaq deal
• Strata Mental Health gets Compass Pathways grant for COMP360 training